RMD

RESMED INC

US StockNYSESurgical & Medical Instruments & Apparatus

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

5.7B USDAnnual · FY 2026

Operating income

1.9B USDAnnual · FY 2026

Net income

1.5B USDAnnual · FY 2026

Total assets

9B USDAnnual · FY 2026

Equity

6.6B USDAnnual · FY 2026

Operating cash flow

1.8B USDAnnual · FY 2026

RMD · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

5.7B USD

Period data
PeriodValue
FY 20223.6B USD
FY 20234.2B USD
FY 20244.7B USD
FY 20255.1B USD
FY 20265.7B USD

Operating income

USD

1.9B USD

Period data
PeriodValue
FY 20221B USD
FY 20231.1B USD
FY 20241.3B USD
FY 20251.7B USD
FY 20261.9B USD

Net income

USD

1.5B USD

Period data
PeriodValue
FY 2022779.4M USD
FY 2023897.6M USD
FY 20241B USD
FY 20251.4B USD
FY 20261.5B USD

Total assets

USD

9B USD

Period data
PeriodValue
FY 20225.1B USD
FY 20236.8B USD
FY 20246.9B USD
FY 20258.2B USD
FY 20269B USD

Equity

USD

6.6B USD

Period data
PeriodValue
FY 20223.4B USD
FY 20234.1B USD
FY 20244.9B USD
FY 20256B USD
FY 20266.6B USD

Operating cash flow

USD

1.8B USD

Period data
PeriodValue
FY 2022351.1M USD
FY 2023693.3M USD
FY 20241.4B USD
FY 20251.8B USD
FY 20261.8B USD

Revenue growth

%

9.9%

Period data
PeriodValue
FY 202211.9%
FY 202318%
FY 202410.9%
FY 20259.8%
FY 20269.9%

Operating income growth

%

11.9%

Period data
PeriodValue
FY 202210.7%
FY 202313.2%
FY 202416.6%
FY 202527.7%
FY 202611.9%

Net income growth

%

8.8%

Period data
PeriodValue
FY 202264.3%
FY 202315.2%
FY 202413.7%
FY 202537.2%
FY 20268.8%

Operating margin

%

33.4%

Period data
PeriodValue
FY 202228%
FY 202326.8%
FY 202428.2%
FY 202532.7%
FY 202633.4%

Net margin

%

26.9%

Period data
PeriodValue
FY 202221.8%
FY 202321.3%
FY 202421.8%
FY 202527.2%
FY 202626.9%

Return on assets

%

17.8%

Period data
PeriodValue
FY 202215.9%
FY 202315.2%
FY 202415%
FY 202518.6%
FY 202617.8%

Debt/Equity

x

0.36x

Period data
PeriodValue
FY 20220.52x
FY 20230.63x
FY 20240.41x
FY 20250.37x
FY 20260.36x